Corcept Therapeutics
CORT
#3340
Rank
$4.28 B
Marketcap
$40.31
Share price
5.75%
Change (1 day)
-64.71%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): $44.79 Million USD

According to Corcept Therapeutics 's latest financial reports the company's current earnings are $0.76 Billion USD. a decrease over its 2024 earnings that were of $0.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 $44.79 M-67.29%
2024 $0.13 B27.66%
2023 $0.10 B-4.75%
2022 $0.11 B-9.51%
2021 $0.12 B-2.91%
2020 $0.12 B14.87%
2019 $0.11 B24.71%
2018 $89.49 M69.32%
2017 $52.85 M419.26%
2016 $10.17 M-395.64%
2015 -$3.45 Million-87.53%
2014 -$27.62 Million-33.44%
2013 -$41.5 Million
2011 -$32.34 Million17.84%
2010 -$27.44 Million35.5%
2009 -$20.25 Million2.84%
2008 -$19.69 Million60.81%
2007 -$12.25 Million-52.14%
2006 -$25.59 Million20.91%
2005 -$21.16 Million31.87%
2004 -$16.05 Million60.54%
2003 -$10 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$33.55 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.35 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$10.19 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$25.73 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$22.42 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.32 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$30.78 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$27.45 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.48 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA